News and Stories

The main asset of a business is its people, without whom organizations could not function. As such, employers are naturally motivated to invest in their workers. But how should they go about improving the health of employees while also improving the company’s bottom line?

Do companies have a responsibility for the health consequences of their products? Should those consequences drive how a company designs its product or service to be used by customers? What are the tradeoffs?

As the health of Americans gets worse, with chronic disease and physical and mental illnesses on the rise, do corporations have a role to play in addressing the health crisis?

Around 150 million Americans rely on employers for access to health care. Can the companies who employ them help foster an affordable system that improves our health and doesn't drive us crazy in the process?

In 2020, HBHI awarded a pilot grant to Jodi Segal, MD, MPH, a HBHI Leadership Committee member and Professor of Medicine at the Johns Hopkins School of Medicine and the Bloomberg School of Public Health to understand what clinicians and patients consider to be appropriate use of telemedicine in primary care to inform future development of a framework that should be valuable to diverse stakeholders.

Mario Macis, PhD of Carey Business School and member of HBHI’s Leadership Committee won a 2020 HBHI pilot grant on “Social Support for Markets in Health and Healthcare: Insights from the COVID-19 Pandemic.” His efforts produced a working paper which was disseminated in April 2022 by the National Bureau of Economic Research (NBER) as well as two research networks in Germany.

Get to know Carey Business School Professor and HBHI Affiliate Emilia Simeonova

Get to know Carey Business School Professor of Econmoics and Management and HBHI Affiliate Mario Macis

Get to know Carey Business School Associate Professor of Managemnet and Organization and HBHI Affiliate Christopher Myers

HBHI convened supply chain scholars and industry leaders to discuss how to prevent supply chain interruptions from occurring when the next pandemic invariably arrives.